SEOUL-- March 30, 2022 -- According to the Fact.MR Latest Analysis, global demand for closed blood sampling systems is slated to experience significant growth at 5.9% CAGR from 2021 to 2032, with the market value set to increase from US$ 76.32 Mn in 2022 to US$ 135.83 Mn by the end of 2032.

As per Fact.MR’s projections, single-line blood sampling systems held a substantial market share of 25.5% in 2021. Closed blood sampling systems accounted for around 0.3% share of the global blood screening market in 2021.

What are the main opportunities for manufacturers of closed blood sampling equipment?

Novel approaches to the prevention of occupational injuries, such as needle stick injuries, are key opportunities for closed blood sampling system providers. Because of the availability of needleless blood sampling systems, this factor is expected to stimulate a lucrative opportunity for the growth of the closed blood sampling systems market, thereby aiding in the prevention of infections associated with needle stick exposure.

Furthermore, the design and engineering of new closed blood sampling systems for neonates and pediatric patients has aided physicians in managing the care of at-risk patients through error-free blood sampling procedures.